| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Knowles Julius is a Director at Keros Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 126 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 47,651 | $57.27 | $2,728,849.30 | -0.7% | -33.8% | -0.0% | |
| Apr 6, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 9,298 | $58.81 | $546,840.09 | -0.3% | -31.6% | +12.6% | |
| Apr 5, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 38,353 | $59.72 | $2,290,536.48 | -0.5% | -33.3% | +4.8% | |
| Mar 4, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 23,959 | $56.45 | $1,352,499.35 | -0.3% | - | - | |
| Mar 2, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 23,690 | $61.13 | $1,448,077.87 | -0.2% | - | - | |
| Feb 18, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 28,617 | $60.87 | $1,742,043.27 | -0.2% | - | - | |
| Feb 12, 2021 | KROS Keros Therapeutics, Inc. | Director | Sell | 19,029 | $63.53 | $1,208,935.69 | -0.2% | - | - | |
| Apr 13, 2020 | KROS Keros Therapeutics, Inc. | Director | Buy | 1,191 | $20.98 | $24,987.18 | New | - | - |